These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16259544)

  • 1. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.
    Villeneuve E; Lemelin S
    J Clin Psychiatry; 2005 Oct; 66(10):1298-303. PubMed ID: 16259544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
    Bellino S; Paradiso E; Bogetto F
    J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
    Van den Eynde F; Senturk V; Naudts K; Vogels C; Bernagie K; Thas O; van Heeringen C; Audenaert K
    J Clin Psychopharmacol; 2008 Apr; 28(2):147-55. PubMed ID: 18344724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quetiapine for the treatment of borderline personality disorder; an open-label study.
    Perrella C; Carrus D; Costa E; Schifano F
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):158-63. PubMed ID: 17045720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.
    Bellino S; Paradiso E; Bogetto F
    Psychiatry Res; 2008 Nov; 161(2):206-12. PubMed ID: 18848360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary evidence of improvement of depressive symptoms but not impulsivity in cluster B personality disorder patients treated with quetiapine: an open label trial.
    Roepke S; Merkl A; Dams A; Ziegenhorn A; Anghelescu IG; Heuser I; Lammers CH
    Pharmacopsychiatry; 2008 Sep; 41(5):176-81. PubMed ID: 18763219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Tolerability of Asenapine Compared with Olanzapine in Borderline Personality Disorder: An Open-Label Randomized Controlled Trial.
    Bozzatello P; Rocca P; Uscinska M; Bellino S
    CNS Drugs; 2017 Sep; 31(9):809-819. PubMed ID: 28741044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
    Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J
    Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH; Cornelius J; George A; Nathan S; Perel JM; Ulrich RF
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine in the treatment of borderline personality disorder.
    Hilger E; Barnas C; Kasper S
    World J Biol Psychiatry; 2003 Jan; 4(1):42-4. PubMed ID: 12582977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder.
    Benedetti F; Sforzini L; Colombo C; Maffei C; Smeraldi E
    J Clin Psychiatry; 1998 Mar; 59(3):103-7. PubMed ID: 9541151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.
    Schulz SC; Camlin KL; Berry SA; Jesberger JA
    Biol Psychiatry; 1999 Nov; 46(10):1429-35. PubMed ID: 10578457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial.
    Black DW; Zanarini MC; Romine A; Shaw M; Allen J; Schulz SC
    Am J Psychiatry; 2014 Nov; 171(11):1174-82. PubMed ID: 24968985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine in patients with borderline personality disorder: an open-label trial.
    Adityanjee ; Romine A; Brown E; Thuras P; Lee S; Schulz SC
    Ann Clin Psychiatry; 2008; 20(4):219-26. PubMed ID: 19034754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.
    McConville BJ; Arvanitis LA; Thyrum PT; Yeh C; Wilkinson LA; Chaney RO; Foster KD; Sorter MT; Friedman LM; Brown KL; Heubi JE
    J Clin Psychiatry; 2000 Apr; 61(4):252-60. PubMed ID: 10830145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia.
    Kasper S; Brecher M; Fitton L; Jones AM
    Int Clin Psychopharmacol; 2004 Sep; 19(5):281-9. PubMed ID: 15289701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB
    Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yi-gan san for the treatment of borderline personality disorder: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashia M; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):150-4. PubMed ID: 17765378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.